We are constantly looking for opportunities to exchange and develop ideas, as they are the foundation for scientific advances and innovation. In addition to our collaboration with academic and commercial partners, attending conferences such as Knowledge for Growth provides us with insights and connections that help us improve our current offerings.
InnoSer is eager to be present at this exciting event organized by Flanders Bio, where we will be happy to discuss our services aimed at accelerating preclinical research. Our Business Development Managers are looking forward to connecting with other life science enthusiasts both at the exhibition but also in meetings with swapcard.
InnoSer has a wide portfolio of in vivo and in vitro services which can be customized to your research project and specific needs. Our various methods can also be combined to improve the reliability and transferability of your data, which is especially important to avoid low success rates in drug development. Besides, Innoser offers not only reliable platforms for drug screening but also facility management services and support with scientific expertise. We are specialized in oncology, polycystic kidney disease, neurodegenerative diseases and cardio-metabolic diseases.
Support in drug development
Outside of our disease specific models and therapeutic expertise InnoSer can provide general contract research services to a range of therapeutic areas. With our fully equipped facilities we are capable of supporting tailored and customized options to support your project no matter your field of interest. Below is a selection of services that could support your research goals and milestones.
Pharmacology/efficacy studies and customized offerings
- Safety, tolerability and toxicology
- PK/PD studies
- Patient-derived xenografts and organoids
- 2D cell culture
- Disease model development
- Medical device testing
Providing high-quality readouts and facility management services
- Implantation von Tumoren
- Contract breeding
- Cryopreservation
- Live cell imaging
- Bioluminescent imaging
- Ultrasound
- Flow cytometry
You can find an overview of our offerings at https://www.innoserlaboratories.com/services/ Interested in getting to know the full scope of our services that support drug development at Knowledge for Growth? We encourage you to book a meeting now using swapcard and get in touch with one of our Business Development Managers. See you soon!
Missed the event but still interested?
Möchten Sie mehr lesen?
![Cognitive profiling in the APP[V717I]xTau[P301S] mouse model](https://www.innoserlaboratories.com/wp-content/uploads/2026/07/Figure-1-MWM.png)
Cognitive profiling in the APP[V717I]xTau[P301S] mouse model
In this month's update, we revisit the APP[V717I]xTau[P301S] model with newly in-house generated Morris Water Maze (MWM) data, reconfirming the spatial memory deficits previously described for this model and reinforcing the translational value of the model.The...
Das Gesamtnierenvolumen (TKV) als translational relevanter, nicht-invasiver Indikator für den Krankheitsverlauf
In unserem Newsletter dieses Monats laden wir Sie ein, zu erfahren, wie die von InnoSer mittels nicht-invasiver Ultraschallbildgebung durchgeführte Langzeitbeurteilung des gesamten Nierenvolumens (TKV) in unserem ADPKD-Mausmodell einen klinisch relevanten strukturellen Messwert liefert, der die Entscheidungsfindung in … direkt unterstützt.
![Translationale Neurowissenschaften: Umfassende Längsschnittuntersuchung von weiblichen und männlichen Mäusen mit Tau[P301S]](https://www.innoserlaboratories.com/wp-content/uploads/2026/06/Female-TauP301S-mice-show-early-spontaneous-hyperactivity-in-automated-home-cages-PhenoTyperTM-229375_400x250.png)
Translationale Neurowissenschaften: Umfassende Längsschnittuntersuchung von weiblichen und männlichen Mäusen mit Tau[P301S]
Im Newsletter dieses Monats stellen wir unsere Erkenntnisse aus der Arbeit mit dem Tau[P301S]-Mausmodell (ursprünglich beschrieben von Allen et al., 2002) vor und gehen näher darauf ein, insbesondere im Hinblick auf dessen Anwendbarkeit in der präklinischen Forschung. Weibliche und männliche...